# Gender Disparity and Hormones in Cystic Fibrosis

> **NCT02036879** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 55 (actual)

## Conditions studied

- Cystic Fibrosis (CF)

## Interventions

- **DRUG:** Loestrin (norethindrone acetate and ethinyl estradiol)

## Key facts

- **NCT ID:** NCT02036879
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2018-08
- **Final completion:** 2018-08
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2020-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02036879

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02036879, "Gender Disparity and Hormones in Cystic Fibrosis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02036879. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*